Product Information
SOD SULFACE-SULF 9.8-4.8% CLSR is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $0.1306 per GM under NDC 42192015610. Its NADAC has been published 368 times since Mar 20, 2019.
Strength
98; 48 mg/g; mg/g
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192015610
Classification
Generic
Dosage Form
LIQUID
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SULFACETAMIDE SODIUM; SULFURApproval Type
Unapproved
On Market Since
12/12/2016
Pharmacological Classes
Price Statistics
The NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has been published 368 times since Mar 20, 2019, and over the history we have for it it has declined 87.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1306 per GM |
|---|---|
| All-time high | $1.0224 (Apr 10, 2019) |
| All-time low | $0.1240 (Apr 22, 2026) |
| 52-week high | $0.1942 |
| 52-week low | $0.1240 |
| Median price | $0.6627 |
| Average price | $0.5590 |
| Largest weekly change | +51.7% (May 17, 2023) |
| Weeks tracked | 368 |
| Tracking since | Mar 20, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SULFACETAMIDE SODIUM, SULFUR market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acella Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SULFACETAMIDE SODIUM, SULFUR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOD SULFACE-SULF 9.8-4.8% CLSR?
The current National Average Drug Acquisition Cost (NADAC) for SOD SULFACE-SULF 9.8-4.8% CLSR, manufactured by Acella Pharmaceuticals, LLC, is $0.1306 per GM (NDC 42192015610), effective Sep 30, 2026.
How has the price of SOD SULFACE-SULF 9.8-4.8% CLSR changed over time?
Over the history we have for it, the NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has declined 87.2%. It has been tracked across 368 weekly CMS publications since Mar 20, 2019.
What are the highest and lowest recorded NADAC prices for SOD SULFACE-SULF 9.8-4.8% CLSR?
Since Mar 20, 2019, the NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has ranged from a low of $0.1240 (Apr 22, 2026) to a high of $1.0224 (Apr 10, 2019), with a median of $0.6627 per GM.
Are there cheaper alternatives to SOD SULFACE-SULF 9.8-4.8% CLSR?
No other NADAC-published product currently shares the active ingredient and strength of SOD SULFACE-SULF 9.8-4.8% CLSR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SOD SULFACE-SULF 9.8-4.8% CLSR?
SOD SULFACE-SULF 9.8-4.8% CLSR (NDC 42192015610) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.